APOLAB ULC PARTNERS WITH THE CANADIAN PHARMACEUTICAL DISTRIBUTION NETWORK
OAKVILLE, ON, March 29, 2016 - The Canadian Pharmaceutical Distribution Network (CPDN), a leading distributor of pharmaceutical products to Canadian hospitals across the country, is pleased to announce its partnership with ApoLab ULC, a state-of-the-art compounding facility providing the highest quality parenteral therapies in a wide array of compounded formulations to hospital pharmacies in Canada.
“We are absolutely delighted that ApoLab has chosen to partner with CPDN for the value-added services we provide our hospital customers", said Sav DiPasquale, President, CPDN. “ApoLab cited our ability to offer easy inventory control and lot traceability as well as accurate daily sales reporting as reasons for joining the CPDN network.”
“For 20 years we have been helping to improve the healthcare of Canadians by providing our partner companies with a cost-effective solution for the ordering and distribution of their healthcare products to hospitals.”
ApoLab is a customized sterile compounding facility committed to preparing the highest quality products, upholding the highest standards in the industry, and supporting clinical care and patient safety. The company received Drug Preparation Premise and Health Canada License in January 2016 and its new Mississauga-based Centralized Intravenous Admixing Pharmacy Service (CIVA) facility has been operational since January 15.